Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease - Wikidata - awgldk - TriplyDB

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

http://www.wikidata.org/entity/Q33703899

about

Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95 Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesi Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death Of mice and men: solving the molecular mysteries of Huntington's disease.Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease.Pathology of CAG repeat diseases.The selective vulnerability of nerve cells in Huntington's disease.Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.Thalamic metabolism and symptom onset in preclinical Huntington's disease.Striatal infusion of glial conditioned medium diminishes huntingtin pathology in r6/1 mice.Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease Genotype-phenotype correlation in CAG-repeat diseases.In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease.Huntington's Disease and Striatal Signaling.Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington's Disease Mice Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease.The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.The protective effect of adenosine A2A receptor antagonism in cerebral ischemia.Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.Novel therapeutic targets for Huntington's disease.Therapeutics development for triplet repeat expansion diseases.The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.Monitoring Huntington's disease progression through preclinical and early stages Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.Transcriptional signatures in Huntington's disease.Drug targeting of dysregulated transcription in Huntington's disease Regulators of adult neurogenesis in the healthy and diseased brain.Huntington's disease: progress and potential in the field.

P2860

Q28142396-8F556251-59BD-43DD-8AF6-420DA31F0C65 Q28510296-47A0AAD9-5ADE-4ADD-815A-89D786FEBCC9 Q30423904-88E27FD5-7B26-4828-AB58-D589984E4517 Q31129663-52E9B524-6956-4EF7-9616-E89871C2D4BF Q33326475-1E16C112-DFDB-405E-8643-68637CC77C55 Q33606063-8A4DA273-4663-404F-B707-BC2517EA3DF1 Q33831774-B03037D9-DA9C-4290-A3CF-671006DDA772 Q33920945-5633D3A6-9A42-4D80-AD80-A4BCC198C5A7 Q33949349-161A9E87-88BD-419F-A6A4-8A9209AED3EB Q33989379-E27EED99-642F-4B72-96EB-2DABDECCB985 Q34075502-88E8F9B7-C48F-48BF-AD48-F0A8C6A1885E Q34135360-89C77B9C-E59B-41D8-8ACB-9DBE49192DF8 Q34152284-7107CD69-7A0B-4935-8F92-5E3C644D4244 Q34158005-C67B2936-2D63-45D0-BEC8-11D27F5EBAD7 Q34216757-4C5F6A77-97BB-4AEF-A8A8-5F053F099A7D Q34689527-389ECA8E-8636-4F63-B895-7BB33F336845 Q34692568-8F14EA70-9D61-4A70-B709-3982E3AA7826 Q34998578-20CE1395-7A84-4A46-9C43-448F7F8D46F1 Q35022005-3919D80E-A2E6-4055-963B-EDBB167364EC Q35058863-66BA5321-B6DC-482D-A4DF-8D4786451F5A Q35116551-3E86A2D6-1F9B-4635-87EB-0B2F67314F54 Q35286098-924CCFED-4129-42B0-8F4F-E2F5482399D2 Q35300868-EC63535C-7DC4-47EE-B9B7-A6A12577851D Q35597460-69822BDE-3C4B-4155-B0F1-229C8905978E Q35982759-63337817-BCC2-4EF3-9262-13982C462B7C Q36016647-864B2140-B359-4DB2-872C-6F87D96DF109 Q36045254-11DD978A-43F6-4892-9608-92B65B0E82BB Q36097335-D33AB943-4C45-4BAE-AD4E-52D46AECCBED Q36100251-25D5F1D4-691A-4561-83B9-9589DE173DF0 Q36219680-3075610D-18E0-4EC2-86B9-BF5747753D9A Q36277195-5196087D-4D09-4E5B-871C-CC859E3C1E97 Q36358871-BAAACBE0-7EF6-426A-BA8F-8D7EA4B10C14 Q36459201-DEF6E453-D137-4C3A-991A-F58AFD900651 Q36589169-6B85508D-FD2E-4342-AA00-7067CEDDF5D0 Q36648659-27008A59-66B8-49B0-9388-FD9B8AE62F74 Q36722685-D3579874-0188-4DD6-B994-A645C07CB849 Q36752799-E03EB5D8-542D-490C-ABF2-1CAE42606FBC Q36767264-ED283A67-4D64-4142-8E37-F1BAB632A6E7 Q36793913-8323350E-82D5-439B-A309-675C64B5EF31 Q37016096-676F1703-248B-4C2F-8A18-686AC1E3C5FF

P2860

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

http://www.wikidata.org/entity/Q33703899

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Altered neurotransmitter recep ...... models of Huntington's disease

@ast

Altered neurotransmitter recep ...... models of Huntington's disease

@en

type

label

Altered neurotransmitter recep ...... models of Huntington's disease

@ast

Altered neurotransmitter recep ...... models of Huntington's disease

@en

prefLabel

Altered neurotransmitter recep ...... models of Huntington's disease

@ast

Altered neurotransmitter recep ...... models of Huntington's disease

@en

P1433

Q33703899-A373D746-9406-45C9-B8F3-C96F68674CB3

P1476

Q33703899-7118583C-BDF9-4079-B011-67B50F2F7A79

P2093

Q33703899-0D47FCDB-E27E-42DB-AC11-C3EB2E79B3A7

Q33703899-4812DF2B-0526-49F8-BF11-7485B4790956

Q33703899-572CA88E-1943-41E0-B771-FBD97049687D

Q33703899-62A50B05-8243-435C-81B0-B9BE51E25AB8

Q33703899-68CD11EC-2596-48FD-AFCB-2DAABD4EC344

Q33703899-B12E4FD7-5FFA-4725-AD6A-887CD612795A

Q33703899-D695FE7C-DCA6-46BB-8BF4-0B72C1177309

Q33703899-E316AFE2-B7C0-4406-99EA-98A20DFE7C5A

Q33703899-EC6CA289-97E7-4541-BE1D-F0246D99B892

Q33703899-F0810D5A-3E91-4F6C-AE75-C3294680974F

P2860

Q33703899-0205DD51-041F-41A1-BE9C-E30BCF55F64B

Q33703899-021E9099-C7E9-4C0D-84AF-CE072B1F35AD

Q33703899-10FE8A47-2032-4F81-B888-4FA5D1C09699

Q33703899-1C8B6345-46CD-4215-A5C0-9622D7E5F4A8

Q33703899-1E68B652-5563-417B-AA95-4F41BDA9A693

Q33703899-1EDABB47-6400-4344-91EC-8AFC66A3F0F4

Q33703899-379FC2C5-666A-469D-8E6F-1D3A3FB86576

Q33703899-38418A6E-6B9D-4A82-A7BF-FCE626B375F2

Q33703899-3AFA9FAB-5668-4528-B4D1-60DF24BDDBDE

Q33703899-431594EF-FBDF-49ED-83D8-A7846F3EE424

P304

Q33703899-2785F468-FC3B-4CED-8EA1-4BB3BBDFDB65

P31

Q33703899-49B7621D-5375-49B9-9265-2BFE76C3E118

P356

Q33703899-B2CDA76F-1FB9-448C-8694-FB442B29F667

P407

Q33703899-EE4A17A5-BB58-46FD-8744-D7B9C419A8EA

P433

Q33703899-17DC9BD8-7AFD-4B21-8DD0-588424FAFE4C

P478

Q33703899-788E4F97-07CD-41A7-A98D-C3D920332355

P577

Q33703899-4E61D9EC-0629-4BE5-A701-35D0667670AF

P5875

Q33703899-678FFD21-0954-4B6A-A5BC-911EFA72841B

P698

Q33703899-DF785D84-55B6-4839-ADFC-E33E1955F3EC

P921

Q33703899-2985A2C5-8D90-4093-B619-A74B0FE24AAD

Q33703899-A0F77B1E-0465-4957-BB1A-806A4C3DE76E

P932

Q33703899-62E10163-744C-4B36-A781-E994F5A886C3

P356

P1433

Philosophical Transactions of the Royal Society B

P1476

Altered neurotransmitter recep ...... models of Huntington's disease

@en

P2093

A B Young

http://www.w3.org/2001/XMLSchema#string

A S Frey

http://www.w3.org/2001/XMLSchema#string

C M Kosinski

http://www.w3.org/2001/XMLSchema#string

G P Bates

http://www.w3.org/2001/XMLSchema#string

J A Kerner

http://www.w3.org/2001/XMLSchema#string

J B Penney

http://www.w3.org/2001/XMLSchema#string

J H Cha

http://www.w3.org/2001/XMLSchema#string

L Mangiarini

http://www.w3.org/2001/XMLSchema#string

S A Alsdorf

http://www.w3.org/2001/XMLSchema#string

S W Davies

http://www.w3.org/2001/XMLSchema#string

P2860

Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.

Alternative excitotoxic hypotheses.

Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

P304

981-989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1098/RSTB.1999.0449

http://www.w3.org/2001/XMLSchema#string

P407

P433

1386

http://www.w3.org/2001/XMLSchema#string

P478

354

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12866070

http://www.w3.org/2001/XMLSchema#string

P698

10434296

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

Huntington disease

P932

1692608

http://www.w3.org/2001/XMLSchema#string